Skip to main content
. 2016 Sep 1;232(4):407–414. doi: 10.1159/000448135

Table 1.

Baseline patient characteristics according to treatment arm

Patient characteristics Monotherapy etanercept (n = 15) Combination therapy etanercept with fumarates (n = 18)
Gender, n
 Males 8 (53) 14 (78)
 Females 7 (47) 4 (22)
Mean age ± SD, years 45±16 43±17
Mean height ± SD, m 1.72±0.13 1.77±0.11
Mean BMI ± SD 30±6* 26±6*
PGA score, n
 Moderate 6 (40) 13 (72)
 Severe 9 (60) 5 (28)
Median PASI score 14 [11, 21] 12 [10,16]
Median DLQI score 9 [5, 20] 8 [3, 13]
Mean duration of psoriasis ± SD, years 19 (10) 22 (10)
History of psoriatic arthritis, n 1 (7) 5 (28)
Prior therapy, n
 UVB/PUVA 15 (93) 17 (94)
 Fumarates 13 (87) 11 (61)
 Methotrexate 13 (87) 13 (72)
 Cyclosporin 4 (27) 6 (33)
 Acitretin 6 (40) 10 (56)
 Biologic 3 (20)* 10 (56)*
*

p < 0.05: statistically significantly different between monotherapy and combination group. Figures in parentheses are percentages, those in square brackets first and third quartiles.